Liu Wen-sheng, Tang Ping-zhang, Qi Yong-fa, Xu Zhen-gang, Li Zheng-jiang
Department of Head and Neck Surgery, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China.
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004 Sep;39(9):562-5.
To investigate the clinical characteristics, treatment and prognosis for poorly differentiated supraglottic carcinomas.
A retrospective study was conducted in 57 cases of poorly differentiated supraglottic carcinomas treated in our hospital from 1980 to 1998. The distribution of the patients according to UICC in 1997 was as follows: stage I 4, stage II 15, stage III 18, stage IV 30. Of the 57 patients, 25 were treated with surgery alone, 9 with irradiation alone, 14 with surgery following preoperative radiation, 7 with postoperative radiation following surgery and 2 with surgery following preoperative chemotherapy. Total laryngectomy was performed on 23 patients and partial laryngectomy on 25 patients. The concurrent neck dissections were undergone for 31 cases (17 unilateral side, 14 bilateral side) and the upper neck dissections for 12 cases.
The overall 5-year survival rate, accumulated cervical metastasis rate, metastasis rate of bilateral side of neck, distant metastasis rate, cervical recurrent rate and locally recurrent rate were 47.4% (27/57), 63.2% (36/57), 24.6% (14/57), 21.1% (12/57), 28.1% (16/57) and 10.5% (6/57), respectively. In addition, the local recurrent rate for partial laryngectomy was 12% (3/25). 5-year survival rate for each TNM staging decreases gradually. The difference in 5-year survival rate between T1 + T2 and T3 + T4 and the difference between N0 + N1 and N2 + N3 were statistically significant (chi2 = 4.942, P = 0.026; chi2 = 4.306, P = 0.038). No evidence in our analysis was found about the difference in 5-year survival rate between surgery alone and surgery combined with radiotherapy. The effect of surgery combined with radiotherapy on patients at N2 and N3 was relatively superior to that of surgery alone.
Poorly differentiated carcinomas of the supraglottic larynx had characteristics of the advanced stage in terms of earlier lymph node metastasis and a relatively high rate of cervical and distant metastasis. Surgery was still the primary treatment for this disease and it was feasible to perform partial laryngectomy on certain patients. For patients with T3 who need partial laryngectomy and patients with advanced N stage, the combination of surgery with radiotherapy was supposed to be a priority.
探讨声门上型低分化癌的临床特征、治疗方法及预后。
对1980年至1998年在我院治疗的57例声门上型低分化癌患者进行回顾性研究。根据1997年国际抗癌联盟(UICC)分期,患者分布如下:Ⅰ期4例,Ⅱ期15例,Ⅲ期18例,Ⅳ期30例。57例患者中,单纯手术治疗25例,单纯放疗9例,术前放疗后手术14例,术后放疗7例,术前化疗后手术2例。23例行全喉切除术,25例行部分喉切除术。31例行同期颈部淋巴结清扫术(17例单侧,14例双侧),12例行上颈部淋巴结清扫术。
总体5年生存率、颈部淋巴结累积转移率、双侧颈部转移率、远处转移率、颈部复发率和局部复发率分别为47.4%(27/57)、63.2%(36/57)、24.6%(14/57)、21.1%(12/57)、28.1%(16/57)和10.5%(6/57)。此外,部分喉切除术的局部复发率为12%(3/25)。各TNM分期的5年生存率逐渐降低。T1+T2与T3+T4之间以及N0+N1与N2+N3之间5年生存率的差异具有统计学意义(χ²=4.942,P=0.026;χ²=4.306,P=0.038)。我们的分析未发现单纯手术与手术联合放疗在5年生存率上的差异。手术联合放疗对N2和N3期患者的疗效相对优于单纯手术。
声门上型低分化癌具有淋巴结转移早、颈部及远处转移率较高的晚期特征。手术仍是本病的主要治疗方法,对部分患者行部分喉切除术是可行的。对于需要行部分喉切除术的T3期患者及晚期N分期患者,手术联合放疗应作为首选。